Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) shares traded up 0.4% during mid-day trading on Thursday . The company traded as high as $44.07 and last traded at $44.07. Approximately 100 shares traded hands during mid-day trading, a decline of 93% from the average session volume of 1,353 shares. The stock had previously closed at $43.88.
Hikma Pharmaceuticals Stock Performance
The business has a 50 day moving average price of $42.85 and a 200 day moving average price of $39.49.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
